Sage Therapeutics is a clinical-stage biopharmaceutical company committed to discovering, developing and delivering novel medicines to transform the lives of patients with life-altering central nervous system (CNS) disorders.

Learn more about our PPD trails


At Sage, we think differently about drug development. We’re originating meaningfully differentiated drug candidates in an effort to bring life-changing treatments to patients and their families. What would you like to discover?


It’s an exciting time in neuroscience. At Sage, we’re developing novel medicines to treat life-altering CNS disorders. Our focused, practical and deliberate approach is designed to facilitate rapid advancement of these potential treatments from discovery through clinical development.


We seek to empower patients and families by bringing hope for conditions where there are gaps in available treatment options. We are working to pioneer new treatment paths for CNS disorders lacking approved standards of care or in need of potentially transformative treatment options. We are rethinking access to care and how it is delivered.